These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1370526)

  • 1. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.
    Lipka JJ; Miyoshi I; Hadlock KG; Reyes GR; Chow TP; Blattner WA; Shaw GM; Hanson CV; Gallo D; Chan L
    J Infect Dis; 1992 Feb; 165(2):268-72. PubMed ID: 1370526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.
    Lipka JJ; Bui K; Reyes GR; Moeckli R; Wiktor SZ; Blattner WA; Murphy EL; Shaw GM; Hanson CV; Sninsky JJ
    J Infect Dis; 1990 Aug; 162(2):353-7. PubMed ID: 1695653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
    Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
    J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
    Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
    J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
    Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
    J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a type-specific protein that differentiates serologically between human T cell lymphotropic virus types I and II.
    Carrera-Zandomeni M; Zandomeni R; Esteban EN; Ferrer JF
    J Infect Dis; 1993 May; 167(5):1021-6. PubMed ID: 8486936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.
    Chen YM; Lee TH; Wiktor SZ; Shaw GM; Murphy EL; Blattner WA; Essex M
    Lancet; 1990 Nov; 336(8724):1153-5. PubMed ID: 1978028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins.
    Rudolph DL; Lal RB
    Clin Chem; 1993 Feb; 39(2):288-92. PubMed ID: 7679339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
    Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.
    Hadlock KG; Lipka JJ; Chow TP; Foung SK; Reyes GR
    Blood; 1992 May; 79(10):2789-96. PubMed ID: 1375112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins.
    Brodine SK; Kaime EM; Roberts C; Turnicky RP; Lal RB
    Transfusion; 1993; 33(11):925-9. PubMed ID: 7903127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
    Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
    Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel monoclonal antibody specifically reactive with human T-lymphotropic virus type-II (HTLV-II) envelope protein.
    Ohara N; Hayashi K; Takahashi K; Miyamoto K; Akagi T
    Int J Cancer; 1993 Jul; 54(5):858-61. PubMed ID: 8325711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II.
    Chironna M; Quarto M; Germinario C; Fontana A
    New Microbiol; 1994 Jul; 17(3):177-85. PubMed ID: 7968652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
    Hadlock KG; Rowe J; Foung SK
    J Virol; 1999 Feb; 73(2):1205-12. PubMed ID: 9882322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.